These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18351533)

  • 1. [Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis].
    Harloff S; Hartwig D; Kasper K; Wedel T; Müller M; Geerling G
    Klin Monbl Augenheilkd; 2008 Mar; 225(3):200-6. PubMed ID: 18351533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment of ocular surface defects: comparison of the epitheliotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model.
    Hartwig D; Herminghaus P; Wedel T; Liu L; Schlenke P; Dibbelt L; Geerling G
    Transfus Med; 2005 Apr; 15(2):107-13. PubMed ID: 15859976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An optimised protocol for the production of autologous serum eyedrops.
    Liu L; Hartwig D; Harloff S; Herminghaus P; Wedel T; Geerling G
    Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):706-14. PubMed ID: 15756576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of serum eye drops after storage of 6 months.
    Fischer KR; Opitz A; Böeck M; Geerling G
    Cornea; 2012 Nov; 31(11):1313-8. PubMed ID: 22955119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal epitheliotrophic capacity of three different blood-derived preparations.
    Liu L; Hartwig D; Harloff S; Herminghaus P; Wedel T; Kasper K; Geerling G
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2438-44. PubMed ID: 16723454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
    Geerling G; Hartwig D
    Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effects of fibronectin and EGF on migration of corneal epithelial cells.
    Watanabe K; Nakagawa S; Nishida T
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):205-11. PubMed ID: 8591897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects?
    Hartwig D; Harloff S; Liu L; Schlenke P; Wedel T; Geerling G
    Transfusion; 2004 Dec; 44(12):1724-31. PubMed ID: 15584987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of epitheliotrophic factors in autologous serum eyedrops from sera of chronic renal failure patients vs. normal controls.
    Kang NH; Lee S; Jun RM
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1705-12. PubMed ID: 26026935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitronectin supports migratory responses of corneal epithelial cells to substrate bound IGF-I and HGF, and facilitates serum-free cultivation.
    Ainscough SL; Barnard Z; Upton Z; Harkin DG
    Exp Eye Res; 2006 Dec; 83(6):1505-14. PubMed ID: 17046752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of corneal epithelial migration by a synthetic peptide (PHSRN) corresponding to the second cell-binding site of fibronectin.
    Kimura K; Hattori A; Usui Y; Kitazawa K; Naganuma M; Kawamoto K; Teranishi S; Nomizu M; Nishida T
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1110-8. PubMed ID: 17325153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye.
    Phasukkijwatana N; Lertrit P; Liammongkolkul S; Prabhasawat P
    Curr Eye Res; 2011 Sep; 36(9):775-81. PubMed ID: 21851164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human corneal epithelial equivalents for ocular surface reconstruction in a complete serum-free culture system without unknown factors.
    Yokoo S; Yamagami S; Usui T; Amano S; Araie M
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2438-43. PubMed ID: 18515584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of autologous serum in the development of corneal and oral epithelial equivalents in patients with Stevens-Johnson syndrome.
    Nakamura T; Ang LP; Rigby H; Sekiyama E; Inatomi T; Sotozono C; Fullwood NJ; Kinoshita S
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):909-16. PubMed ID: 16505023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of persistent corneal epithelial defect by autologous serum application.
    Tsubota K; Goto E; Shimmura S; Shimazaki J
    Ophthalmology; 1999 Oct; 106(10):1984-9. PubMed ID: 10519596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation].
    Herminghaus P; Geerling G; Hartwig D; Wedel T; Dibbelt L
    Ophthalmologe; 2004 Oct; 101(10):998-1005. PubMed ID: 15095107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aggregated human gamma-globin on leukocyte migration-inhibitory test in patients with rheumatoid arthritis.
    Janicka U; Mackiewicz S
    Pol Med Sci Hist Bull (1973); 1976; 15(3):301-4. PubMed ID: 995766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells.
    Geerling G; Daniels JT; Dart JK; Cree IA; Khaw PT
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):948-56. PubMed ID: 11274071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of corneal epitheliotrophic capacity among different human blood-derived preparations.
    Shen EP; Hu FR; Lo SC; Chen YM; Sun YC; Lin CT; Chen WL
    Cornea; 2011 Feb; 30(2):208-14. PubMed ID: 21045671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
    Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.